ApprovalTrail

Ingredient

Rivastigmine

Products in Health Canada’s databases that list Rivastigmine as a medicinal or active ingredient. Its salts and forms that the databases name on their own have their own pages.

Also listed as “Rivastigmine (Rivastigmine Hydrogen Tartrate)” (65). How names are joined

Drug products
80
35 authorized now
Natural health products
0
0 active licences
Notices of Compliance
25
Products in all
80

Drug products

Authorized products first.

NameDINStatus
APO-RIVASTIGMINE (1.5 MG)Apotex Inc. · Status since Apr 201002336715Marketed
APO-RIVASTIGMINE (3 MG)Apotex Inc. · Status since Apr 201002336723Marketed
APO-RIVASTIGMINE (4.5 MG)Apotex Inc. · Status since Apr 201002336731Marketed
APO-RIVASTIGMINE (6 MG)Apotex Inc. · Status since Apr 201002336758Marketed
EXELON (1.5 MG)Knight Therapeutics Inc. · Status since Nov 202202242115Marketed
EXELON (3 MG)Knight Therapeutics Inc. · Status since Dec 202202242116Marketed
EXELON (4.5 MG)Knight Therapeutics Inc. · Status since Nov 202202242117Marketed
EXELON (6 MG)Knight Therapeutics Inc. · Status since Nov 202202242118Marketed
EXELON (2 MG)Knight Therapeutics Inc. · Status since Nov 202202245240Marketed
EXELON PATCH 10 (9.5 MG)Knight Therapeutics Inc. · Status since Nov 202202302853Marketed
EXELON PATCH 15 (13.3 MG)Knight Therapeutics Inc. · Status since Oct 202202432803Marketed
EXELON PATCH 5 (4.6 MG)Knight Therapeutics Inc. · Status since Oct 202202302845Marketed
JAMP RIVASTIGMINE (1.5 MG)JAMP Pharma Corporation · Status since Feb 202002485362Marketed
JAMP RIVASTIGMINE (3 MG)JAMP Pharma Corporation · Status since Feb 202002485370Marketed
JAMP RIVASTIGMINE (4.5 MG)JAMP Pharma Corporation · Status since Feb 202002485389Marketed
JAMP RIVASTIGMINE (6 MG)JAMP Pharma Corporation · Status since Feb 202002485397Marketed
JAMP RIVASTIGMINE CAPSULES (1.5 MG)JAMP Pharma Corporation · Status since Jul 202502552256Marketed
JAMP RIVASTIGMINE CAPSULES (3 MG)JAMP Pharma Corporation · Status since Jul 202502552264Marketed
JAMP RIVASTIGMINE CAPSULES (4.5 MG)JAMP Pharma Corporation · Status since Jul 202502552272Marketed
JAMP RIVASTIGMINE CAPSULES (6 MG)JAMP Pharma Corporation · Status since Jul 202502552280Marketed
MED-RIVASTIGMINE (1.5 MG)Generic Medical Partners Inc · Status since Nov 201302401614Marketed
MED-RIVASTIGMINE (3 MG)Generic Medical Partners Inc · Status since Nov 201302401622Marketed
MED-RIVASTIGMINE (4.5 MG)Generic Medical Partners Inc · Status since Nov 201402401630Marketed
MED-RIVASTIGMINE (6 MG)Generic Medical Partners Inc · Status since Nov 201302401649Marketed
MYLAN-RIVASTIGMINE PATCH 10 (9.5 MG)Mylan Pharmaceuticals Ulc · Status since Dec 201602423421Marketed
MYLAN-RIVASTIGMINE PATCH 5 (4.6 MG)Mylan Pharmaceuticals Ulc · Status since Dec 201602423413Marketed
SANDOZ RIVASTIGMINE PATCH 10 (9.5 MG)Sandoz Canada Inc. · Status since Nov 201602426307Marketed
SANDOZ RIVASTIGMINE PATCH 5 (4.6 MG)Sandoz Canada Inc. · Status since Nov 201602426293Marketed
AURO-RIVASTIGMINE (1.5 MG)Auro Pharma Inc. · Status since Aug 201802427567Dormant
AURO-RIVASTIGMINE (3 MG)Auro Pharma Inc. · Status since Aug 201802427575Dormant
AURO-RIVASTIGMINE (4.5 MG)Auro Pharma Inc. · Status since Aug 201802427583Dormant
AURO-RIVASTIGMINE (6 MG)Auro Pharma Inc. · Status since Aug 201802427591Dormant
RIVASTIGMINE PATCH 10 (9.5 MG)Pharmascience Inc. · Status since Jul 202402479559Dormant
RIVASTIGMINE PATCH 15 (13.3 MG)Pharmascience Inc. · Status since Jul 202402479567Dormant
RIVASTIGMINE PATCH 5 (4.6 MG)Pharmascience Inc. · Status since Jul 202402479540Dormant
ACT RIVASTIGMINE PATCH 10 (18 MG)Actavis Pharma Company · Status since Jul 201802423537Cancelled Pre Market
ACT RIVASTIGMINE PATCH 5 (9 MG)Actavis Pharma Company · Status since Jul 201802423529Cancelled Pre Market
DOM-RIVASTIGMINE (1.5 MG)Dominion Pharmacal · Status since Jul 202602307685Cancelled Pre Market
DOM-RIVASTIGMINE (3.0 MG)Dominion Pharmacal · Status since Jul 202602307693Cancelled Pre Market
DOM-RIVASTIGMINE (4.5 MG)Dominion Pharmacal · Status since Jul 202602307707Cancelled Pre Market
DOM-RIVASTIGMINE (6.0 MG)Dominion Pharmacal · Status since Jul 202602307715Cancelled Pre Market
MINT-RIVASTIGMINE (1.5 MG)Mint Pharmaceuticals Inc · Status since Jun 201702406985Cancelled Post Market
MINT-RIVASTIGMINE (3 MG)Mint Pharmaceuticals Inc · Status since Jun 201702406993Cancelled Post Market
MINT-RIVASTIGMINE (4.5 MG)Mint Pharmaceuticals Inc · Status since Jun 201702407000Cancelled Post Market
MINT-RIVASTIGMINE (6 MG)Mint Pharmaceuticals Inc · Status since Jun 201702407019Cancelled Post Market
MYLAN-RIVASTIGMINE (1.5 MG)Mylan Pharmaceuticals Ulc · Status since Nov 201602332809Cancelled Post Market
MYLAN-RIVASTIGMINE (3 MG)Mylan Pharmaceuticals Ulc · Status since Nov 201602332817Cancelled Post Market
MYLAN-RIVASTIGMINE (4.5 MG)Mylan Pharmaceuticals Ulc · Status since Nov 201602332825Cancelled Post Market
MYLAN-RIVASTIGMINE (6 MG)Mylan Pharmaceuticals Ulc · Status since Nov 201602332833Cancelled Post Market
NOVO-RIVASTIGMINE (1.5 MG)Novopharm Limited · Status since May 201802305984Cancelled Post Market
NOVO-RIVASTIGMINE (3 MG)Novopharm Limited · Status since May 201802305992Cancelled Post Market
NOVO-RIVASTIGMINE (4.5 MG)Novopharm Limited · Status since May 201802306018Cancelled Post Market
NOVO-RIVASTIGMINE (6 MG)Novopharm Limited · Status since May 201802306026Cancelled Post Market
PHL-RIVASTIGMINE (1.5 MG)Pharmel Inc. · Status since Sep 201702308169Cancelled Pre Market
PHL-RIVASTIGMINE (3.0 MG)Pharmel Inc. · Status since Sep 201702308177Cancelled Pre Market
PHL-RIVASTIGMINE (4.5 MG)Pharmel Inc. · Status since Sep 201702308185Cancelled Pre Market
PHL-RIVASTIGMINE (6.0 MG)Pharmel Inc. · Status since Sep 201702308193Cancelled Pre Market
PMS-RIVASTIGMINE (1.5 MG)Pharmascience Inc. · Status since Jul 202502306034Cancelled Post Market
PMS-RIVASTIGMINE (3.0 MG)Pharmascience Inc. · Status since Jul 202502306042Cancelled Post Market
PMS-RIVASTIGMINE (4.5 MG)Pharmascience Inc. · Status since Jul 202502306050Cancelled Post Market
PMS-RIVASTIGMINE (6.0 MG)Pharmascience Inc. · Status since Jul 202502306069Cancelled Post Market
PRIVA-RIVASTIGMINE (4.6 MG)Pharmapar Inc. · Status since Jul 202102490153Cancelled Pre Market
PRIVA-RIVASTIGMINE (9.5 MG)Pharmapar Inc. · Status since Jul 202102490161Cancelled Pre Market
PRIVA-RIVASTIGMINE (13.3 MG)Pharmapar Inc. · Status since Jul 202102490188Cancelled Pre Market
RATIO-RIVASTIGMINE (1.5 MG)Teva Canada Limited · Status since May 201802311283Cancelled Post Market
RATIO-RIVASTIGMINE (3 MG)Teva Canada Limited · Status since May 201802311291Cancelled Post Market
RATIO-RIVASTIGMINE (4.5 MG)Teva Canada Limited · Status since May 201802311305Cancelled Post Market
RATIO-RIVASTIGMINE (6 MG)Teva Canada Limited · Status since May 201802311313Cancelled Post Market
RIVASTIGMINE (1.5 MG)Pro Doc Limitee · Status since Apr 202502416999Cancelled Post Market
RIVASTIGMINE (3 MG)Pro Doc Limitee · Status since Apr 202502417006Cancelled Post Market
RIVASTIGMINE (4.5 MG)Pro Doc Limitee · Status since Apr 202502417014Cancelled Post Market
RIVASTIGMINE (6 MG)Pro Doc Limitee · Status since Jun 202502417022Cancelled Post Market
RIVASTIGMINE TARTRATE CAPSULES (1.5 MG)Dr Reddy's Laboratories Ltd · Status since Jul 202202375729Cancelled Pre Market
RIVASTIGMINE TARTRATE CAPSULES (3.0 MG)Dr Reddy's Laboratories Ltd · Status since Jul 202202375737Cancelled Pre Market
RIVASTIGMINE TARTRATE CAPSULES (4.5 MG)Dr Reddy's Laboratories Ltd · Status since Jul 202202375745Cancelled Pre Market
RIVASTIGMINE TARTRATE CAPSULES (6.0 MG)Dr Reddy's Laboratories Ltd · Status since Jul 202202375753Cancelled Pre Market
SANDOZ RIVASTIGMINE (1.5 MG)Sandoz Canada Inc. · Status since Jul 202602324563Cancelled Post Market
SANDOZ RIVASTIGMINE (3 MG)Sandoz Canada Inc. · Status since Jul 202602324571Cancelled Post Market
SANDOZ RIVASTIGMINE (4.5 MG)Sandoz Canada Inc. · Status since Jul 202602324598Cancelled Post Market
SANDOZ RIVASTIGMINE (6 MG)Sandoz Canada Inc. · Status since Jul 202602324601Cancelled Post Market

Notices of Compliance

Approvals of drug submissions that list it, newest first.